Vendor source
Reviewed 17 Jun 2026
Completeness Strong (64%)
GadoBoost AI virtually enhances contrast uptake in T1-weighted 3D brain MRI scans and automatically detects contrast-enhancing lesions. It is particularly designed for scenarios where subtle findings need to be identified, such as follow-up examinations of patients with cancers that commonly metastasize to the brain. By increasing the conspicuity of subtle enhancing findings and supporting radiologists with automated detection, GadoBoost AI aims to improve confidence during routine assessment of potentially negative examinations.
No papers to support — we monitor for new evidence.


General Information
Product name
Company
Modality
Main task
Subspeciality
Disease targeted
Not specified
Regulatory Information
Pathway:
MDR
Class:
Class IIa
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Technical Specifications
Patient population age
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Not specified
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Based on
Source: Vendor | First published: Jun 17, 2026 | Last updated: Jun 17, 2026